Calcium and S100B Regulation of P53-dependent Cell Growth Arrest and Apoptosis

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 1998 Jun 25

PMID 9632811

Citations 28

Authors

C Scotto

J C Deloulme

D Rousseau

E Chambaz

J Baudier

Affiliations

Soon will be listed here.

Abstract

In glial C6 cells constitutively expressing wild-type p53, synthesis of the calcium-binding protein S100B is associated with cell density-dependent inhibition of growth and apoptosis in response to UV irradiation. A functional interaction between S100B and p53 was first demonstrated in p53-negative mouse embryo fibroblasts (MEF cells) by sequential transfection with the S100B and the temperature-sensitive p53Val135 genes. We show that in MEF cells expressing a low level of p53Val135, S100B cooperates with p53Val135 in triggering calcium-dependent cell growth arrest and cell death in response to UV irradiation at the nonpermissive temperature (37.5 degreesC). Calcium-dependent growth arrest of MEF cells expressing S100B correlates with specific nuclear accumulation of the wild-type p53Val135 conformational species. S100B modulation of wild-type p53Val135 nuclear translocation and functions was confirmed with the rat embryo fibroblast (REF) cell line clone 6, which is transformed by oncogenic Ha-ras and overexpression of p53Val135. Ectopic expression of S100B in clone 6 cells restores contact inhibition of growth at 37.5 degreesC, which also correlates with nuclear accumulation of the wild-type p53Val135 conformational species. Moreover, a calcium ionophore mediates a reversible G1 arrest in S100B-expressing REF (S100B-REF) cells at 37.5 degreesC that is phenotypically indistinguishable from p53-mediated G1 arrest at the permissive temperature (32 degreesC). S100B-REF cells proceeding from G1 underwent apoptosis in response to UV irradiation. Our data support a model in which calcium signaling and S100B cooperate with the p53 pathways of cell growth inhibition and apoptosis.

Citing Articles

S100B actions on glial and neuronal cells in the developing brain: an overview.

Hernandez-Ortega K, Canul-Euan A, Solis-Paredes J, Borboa-Olivares H, Reyes-Munoz E, Estrada-Gutierrez G Front Neurosci. 2024; 18:1425525.

PMID: 39027325 PMC: 11256909. DOI: 10.3389/fnins.2024.1425525.

CRISPR/dCas9-KRAB-Mediated Suppression of Restores p53-Mediated Apoptosis in Melanoma Cells.

Roy Choudhury S, Heflin B, Taylor E, Koss B, Avaritt N, Tackett A Cells. 2023; 12(5).

PMID: 36899866 PMC: 10000373. DOI: 10.3390/cells12050730.

Prognostic properties of the association between the S-100B protein levels and the mean cerebral blood flow velocity in patients diagnosed with severe traumatic brain injury.

Dzierzecki S, Zabek M, Zaczynski A, Tomasiuk R Biomed Rep. 2022; 17(1):58.

PMID: 35719835 PMC: 9201289. DOI: 10.3892/br.2022.1541.

Phosphodiesterase-5 Inhibitor Attenuates Anxious Phenotypes and Movement Disorder Induced by Mild Ischemic Stroke in Rats.

Yu Y, Kim S, Kang J, Song Y, Im H, Kim S J Korean Neurosurg Soc. 2022; 65(5):665-679.

PMID: 35430790 PMC: 9452378. DOI: 10.3340/jkns.2021.0101.

The S100B Protein and Partners in Adipocyte Response to Cold Stress and Adaptive Thermogenesis: Facts, Hypotheses, and Perspectives.

Baudier J, Gentil B Biomolecules. 2020; 10(6).

PMID: 32486507 PMC: 7356379. DOI: 10.3390/biom10060843.

References

Aloni-Grinstein R, Schwartz D, Rotter V . Accumulation of wild-type p53 protein upon gamma-irradiation induces a G2 arrest-dependent immunoglobulin kappa light chain gene expression. EMBO J. 1995; 14(7):1392-401. PMC: 398224. DOI: 10.1002/j.1460-2075.1995.tb07125.x. View

Heizmann C, Braun K . Changes in Ca(2+)-binding proteins in human neurodegenerative disorders. Trends Neurosci. 1992; 15(7):259-64. DOI: 10.1016/0166-2236(92)90067-i. View

McConkey D, Orrenius S . Signal transduction pathways to apoptosis. Trends Cell Biol. 1994; 4(10):370-5. DOI: 10.1016/0962-8924(94)90087-6. View

Marshak D, Pesce S, Stanley L, Griffin W . Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiol Aging. 1992; 13(1):1-7. DOI: 10.1016/0197-4580(92)90002-f. View

Labourdette G, Marks A . Synthesis of S-100 protein in monolayer cultures of rat-glial cells. Eur J Biochem. 1975; 58(1):73-9. DOI: 10.1111/j.1432-1033.1975.tb02350.x. View

Fano G, Mariggio M, Angelella P, Nicoletti I, Antonica A, Fulle S . The S-100 protein causes an increase of intracellular calcium and death of PC12 cells. Neuroscience. 1993; 53(4):919-25. DOI: 10.1016/0306-4522(93)90477-w. View

Barak Y, Juven T, Haffner R, Oren M . mdm2 expression is induced by wild type p53 activity. EMBO J. 1993; 12(2):461-8. PMC: 413229. DOI: 10.1002/j.1460-2075.1993.tb05678.x. View

Griffin W, Stanley L, Ling C, White L, MacLeod V, Perrot L . Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A. 1989; 86(19):7611-5. PMC: 298116. DOI: 10.1073/pnas.86.19.7611. View

Baudier J, Glasser N, Gerard D . Ions binding to S100 proteins. I. Calcium- and zinc-binding properties of bovine brain S100 alpha alpha, S100a (alpha beta), and S100b (beta beta) protein: Zn2+ regulates Ca2+ binding on S100b protein. J Biol Chem. 1986; 261(18):8192-203. View

10.

Milner J . Flexibility: the key to p53 function?. Trends Biochem Sci. 1995; 20(2):49-51. DOI: 10.1016/s0968-0004(00)88954-9. View

11.

Caelles C, Helmberg A, Karin M . p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature. 1994; 370(6486):220-3. DOI: 10.1038/370220a0. View

12.

Georgoff I, Martinez J, Levine A . Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev. 1991; 5(2):151-9. DOI: 10.1101/gad.5.2.151. View

13.

Schagger H, von Jagow G . Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem. 1987; 166(2):368-79. DOI: 10.1016/0003-2697(87)90587-2. View

14.

El-Deiry W, Tokino T, Velculescu V, Levy D, Parsons R, Trent J . WAF1, a potential mediator of p53 tumor suppression. Cell. 1993; 75(4):817-25. DOI: 10.1016/0092-8674(93)90500-p. View

15.

Herschman H, Levine L, de Vellis J . Appearance of a brain-specific antigen (S-100 protein) in the developing rat brain. J Neurochem. 1971; 18(4):629-33. DOI: 10.1111/j.1471-4159.1971.tb11993.x. View

16.

Morii K, Tanaka R, Takahashi Y, Kuwano R . Cloning of cDNAs encoding human S-100 alpha and beta subunits and their differential expression in human tumor cell lines. J Neurosci Res. 1992; 32(1):27-33. DOI: 10.1002/jnr.490320104. View

17.

Yahanda A, Bruner J, Donehower L, Morrison R . Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas. Mol Cell Biol. 1995; 15(8):4249-59. PMC: 230664. DOI: 10.1128/MCB.15.8.4249. View

18.

He J, DeCastro C, Vandenbark G, Busciglio J, Gabuzda D . Astrocyte apoptosis induced by HIV-1 transactivation of the c-kit protooncogene. Proc Natl Acad Sci U S A. 1997; 94(8):3954-9. PMC: 20549. DOI: 10.1073/pnas.94.8.3954. View

19.

Vikhanskaya F, Erba E, DIncalci M, Broggini M . Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53. Exp Cell Res. 1996; 227(2):380-5. DOI: 10.1006/excr.1996.0288. View

20.

Asai A, Miyagi Y, Sugiyama A, Gamanuma M, Hong S, Takamoto S . Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy. J Neurooncol. 1994; 19(3):259-68. DOI: 10.1007/BF01053280. View